Cycloset
Generic name: Bromocriptine
Usage of Cycloset
Cycloset tablets contain micronized bromocriptine in a quick release formulation.
Cycloset is used together with diet and exercise to improve blood sugar control in adults with type 2 type 2 diabetes mellitus.
Cycloset is not for treating type 1 diabetes.
This medication guide provides information about the Cycloset brand of bromocriptine. Parlodel is another brand of bromocriptine that is not covered in this medication guide.
Cycloset side effects
Get emergency medical help if you have signs of an allergic reaction to Cycloset: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
You may have increased sexual urges, unusual urges to gamble, or other intense urges while taking this medicine. Talk with your doctor if this occurs.
Common Cycloset side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Cycloset
You should not use Cycloset if you are allergic to bromocriptine or to an ergot medicine (dihydroergotamine, ergotamine, ergonovine, methylergonovine).
You should not use Cycloset if:
To make sure Cycloset is safe for you, tell your doctor if you have:
Follow your doctor's instructions about using this medicine if you are pregnant or you become pregnant. Controlling diabetes is very important during pregnancy, and having high blood sugar may cause complications in both the mother and the baby.
Do not breastfeed while using this medicine.
How to use Cycloset
Usual Adult Dose for Diabetes Type 2:
Initial: 0.8 mg orally once a day -Increase in increments of 0.8 mg weekly as tolerated Maintenance: 1.6 to 4.8 mg orally once a day Maximum Dose: 4.8 mg/day Dose should be taken within 2 hours of waking in the morning with food Concomitant Administration with CYP450 3A4 inhibitors: -Moderate CYP450 3A4 inhibitors (e.g., erythromycin): Do not exceed 1.6 mg/day -Strong CYP450 3A4 inhibitors (e,g., azole antimycotics, HIV protease inhibitors): Avoid concomitant use and ensure adequate washout of strong CYP450 3A4 inhibitors before initiating therapy Comments: -Not for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis -Limited efficacy data in combination with thiazolidinediones -Efficacy has not been confirmed in combination with insulin Use: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Warnings
You should not use Cycloset if you have migraine headaches that cause you to faint, if you are in a state of diabetic ketoacidosis, or if you recently had a baby.
Do not breastfeed.
Tell your doctor right away if you become pregnant while taking Cycloset.
What other drugs will affect Cycloset
Cycloset can make certain migraine headache medicines less effective when taken at the same time. Avoid taking Cycloset within 6 hours before or 6 hours after you take an ergot headache medicine (such as dihydroergotamine, ergotamine, ergonovine, methylergonovine).
Tell your doctor about all your current medicines. Many drugs can interact with bromocriptine, especially medicine to treat:
This list is not complete and many other drugs may interact with bromocriptine. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions